Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Patent litigation: 3.28M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Patent litigation: 3.28M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q2 EPS of $0.60, $0.24 better than the analyst estimate of $0.36. Revenue for the quarter came in at $188.1 million versus the consensus estimate of $155.97 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
